The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Episomal Vectors Rapidly and Stably Produce High-Titer Recombinant Retrovirus
Abstract
The nuclear replication and retention functions of the Epstein–Barr virus (EBV) have been utilized here to maintain retroviral constructs episomally within human cell-based retroviral packaging lines. These hybrid EBV/retroviral constructs are capable of producing helper-free recombinant retrovirus as soon as 48 hr and for at least 30 days after transfection into 293T-based ecotropic and/or amphotropic retroviral packaging cells. Viral titers greater than 107 TU/ml were obtained after puromycin selection of transfected retroviral packaging cells. This episomal approach to retroviral production circumvents some limitations inherent in transient and chromosomally stable retroviral producer systems, affording reproducibly rapid, large-scale, stable, and high-titer retrovirus production. Producing high-titer retrovirus can be a limiting factor in the successful application of retroviruses for gene transduction. A retroviral producer system capable of both rapid and long-term virus production would circumvent many of the restrictions inherent to chromosomal-stable and/or transient-based production methods. It is demonstrated here that replication and nuclear retention functions of the human Epstein–Barr virus (EBV) can confer stable episomal maintenance to retroviral constructs within human cell-based packaging lines. Such hybrid EBV/retroviral constructs permit both rapid and long-term production of high-titer retrovirus. Furthermore, it is demonstrated that these constructs are not prone to arrangements when maintained episomally in packaging cells and that viral stocks are helper-virus free.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146
Production of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Self-citationMorgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,101
Mann, R., Mulligan, R. C., & Baltimore, D. (1983) · Cell · doi:10.1016/0092-8674(83)90344-6 · Cited by 1,805
The Basic Science of Gene Therapy
Mulligan, R. C. (1993) · Science · doi:10.1126/science.8493530 · Cited by 1,741
Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells
Yates, J. L., Warren, N., & Sugden, B. (1985) · Nature · doi:10.1038/313812a0 · Cited by 1,292
Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.
DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H., & Calos, M. P. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.1.379 · Cited by 1,133
In vivo sequence requirements of the SV40 early promoter region
Benoist, C., & Chambon, P. (1981) · Nature · doi:10.1038/290304a0 · Cited by 1,074 · cited 1×
“The puromycin-resistance gene is present within the retroviral backbone and is under the transcriptional control of the SV40 early promoter (Benoist and Chambon, 1981; Fromm and Berg, 1982). pBabePuro(ASV40) is a derivative of pBabePuro in which the SV40 early promoter has been removed by digestion…”
Yeh, W. C., Cao, Z., Classon, M., & McKnight, S. L. (1995) · Genes & Development · doi:10.1101/gad.9.2.168 · Cited by 935
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer.
Price, J., Turner, D., & Cepko, C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.156 · Cited by 873
Yates, J., Warren, N., Reisman, D., & Sugden, B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3806 · Cited by 668
Rawlins, D. R., Milman, G., Hayward, S. D., & Hayward, G. S. (1985) · Cell · doi:10.1016/0092-8674(85)90282-x · Cited by 506
Nolan, G. P., Fiering, S., Nicolas, J. F., & Herzenberg, L. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2603 · Cited by 476
Self-citationMiller, A. D. (1990) · Human Gene Therapy · doi:10.1089/hum.1990.1.1-5 · Cited by 385
Reisman, D., & Sugden, B. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.11.3838 · Cited by 366
Deletion mapping of DNA regions required for SV40 early region promoter function in vivo.
Fromm, M., & Berg, P. R. (1982) · PubMed · Cited by 330
Dai, Y., Roman, M., Naviaux, R. K., & Verma, I. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10892 · Cited by 302
Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog
Fan, H., Oro, A. E., Scott, M. P., & Khavari, P. A. (1997) · Nature Medicine · doi:10.1038/nm0797-788 · Cited by 276
Lupton, S., & Levine, A. J. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2533 · Cited by 274
Heemskerk, M. H. M., Blom, B., Nolan, G., Stegmann, A. P. A., Bakker, A. Q., Weijer, K., Res, P. C. M., & Spits, H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1597 · Cited by 273
Self-citationPackaging system for rapid production of murine leukemia virus vectors with variable tropism
Landau, N. R., & Littman, D. R. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.5110-5113.1992 · Cited by 255
Isolation of human sequences that replicate autonomously in human cells.
Krysan, P. J., Haase, S. B., & Calos, M. P. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1026 · Cited by 243
Efficient screening of retroviral cDNA expression libraries.
Kitamura, T., Onishi, M., Kinoshita, S., Shibuya, A., Miyajima, A., & Nolan, G. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9146 · Cited by 241
Self-citationkat: a high-efficiency retroviral transduction system for primary human T lymphocytes
Finer, M., Dull, T., Qin, L., Farson, D., & Roberts, M. (1994) · Blood · doi:10.1182/blood.v83.1.43.43 · Cited by 224
Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors.
Watanabe, S., & Temin, H. M. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.12.2241 · Cited by 214
Replication of latent Epstein-Barr virus genomes in Raji cells
Adams, A. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1743-1746.1987 · Cited by 198
Reisman, D., Yates, J., & Sugden, B. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.8.1822-1832.1985 · Cited by 186
Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker
de la Luna, S., Soria, I., Pulido, D., Ortín, J., & Jiménez, A. (1988) · Gene · doi:10.1016/0378-1119(88)90585-9 · Cited by 144
Direct Cutaneous Gene Delivery in a Human Genetic Skin Disease
Choate, K. A., & Khavari, P. A. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.14-1659 · Cited by 100
Fas Signal Transduction Triggers Either Proliferation or Apoptosis in Human Fibroblasts
Freiberg, R. A., Spencer, D. M., Choate, K. A., Duh, H. J., Schreiber, S. L., Crabtree, G. R., & Khavari, P. A. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12334273 · Cited by 95
Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells
Heinzel, S. S., Krysan, P. J., Calos, M. P., & DuBridge, R. B. (1988) · Journal of Virology · doi:10.1128/jvi.62.10.3738-3746.1988 · Cited by 88
Sustainable cutaneous gene delivery
Deng, H., Lin, Q., & Khavari, P. A. (1997) · Nature Biotechnology · doi:10.1038/nbt1297-1388 · Cited by 87
Epstein-Barr virus-based vectors that replicate in rodent cells
Krysan, P. J., & Calos, M. P. (1993) · Gene · doi:10.1016/0378-1119(93)90457-e · Cited by 75
Whole Animal Cell Sorting of Drosophila Embryos
Krasnow, M. A., Cumberledge, S., Manning, G., Herzenberg, L. A., & Nolan, G. P. (1991) · Science · doi:10.1126/science.1898782 · Cited by 48
Self-citationHaase, S. B., Heinzel, S. S., Krysan, P. J., & Calos, M. P. (1989) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(89)90018-3 · Cited by 8
Cited by
PRDM16 controls a brown fat/skeletal muscle switch
Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scimè, A., Devarakonda, S., Conroe, H. M., Erdjument-Bromage, H., et al. (2008) · Nature · doi:10.1038/nature07182 · Cited by 2,347
Debnath, J., Muthuswamy, S. K., & Brugge, J. S. (2003) · Methods · doi:10.1016/s1046-2023(03)00032-x · Cited by 1,995
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
Transcriptional Control of Brown Fat Determination by PRDM16
Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L. M., Uldry, M., Tavernier, G., Langin, D., & Spiegelman, B. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.001 · Cited by 1,174
Metadata
- Authors
- Kinsella, T. M., & Nolan, G. P.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1996-08
- Volume
- 7
- Issue
- 12
- Pages
- 1405-1413
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W1977225005
- Cited by
- 734
- References
- 35
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.